Kistler-Tiffany Companies’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $52.6K | Hold |
1,281
| – | – | 0.01% | 483 |
|
|
2023
Q1 | $45.8K | Hold |
1,281
| – | – | 0.01% | 445 |
|
|
2022
Q4 | $48.4K | Hold |
1,281
| – | – | 0.01% | 425 |
|
|
2022
Q3 | $57K | Hold |
1,281
| – | – | 0.01% | 367 |
|
|
2022
Q2 | $47K | Hold |
1,281
| – | – | 0.01% | 384 |
|
|
2022
Q1 | $47K | Hold |
1,281
| – | – | 0.01% | 398 |
|
|
2021
Q4 | $39K | Hold |
1,281
| – | – | 0.01% | 404 |
|
|
2021
Q3 | $43K | Hold |
1,281
| – | – | 0.01% | 386 |
|
|
2021
Q2 | $51K | Sell |
1,281
-300
| -19% | -$11.8K | 0.01% | 366 |
|
|
2021
Q1 | $71K | Sell |
1,581
-425
| -21% | -$23.7K | 0.02% | 288 |
|
|
2020
Q4 | $113K | Hold |
2,006
| – | – | 0.03% | 212 |
|
|
2020
Q3 | $95K | Hold |
2,006
| – | – | 0.03% | 216 |
|
|
2020
Q2 | $118K | Hold |
2,006
| – | – | 0.04% | 182 |
|
|
2020
Q1 | $121K | Hold |
2,006
| – | – | 0.04% | 178 |
|
|
2019
Q4 | $121K | Hold |
2,006
| – | – | 0.04% | 184 |
|
|
2019
Q3 | $120K | Buy |
2,006
+181
| +10% | +$11.8K | 0.05% | 182 |
|
|
2019
Q2 | $117K | Hold |
1,825
| – | – | 0.04% | 177 |
|
|
2019
Q1 | $148K | Sell |
1,825
-75
| -4% | -$4.84K | 0.06% | 154 |
|
|
2018
Q4 | $103K | Hold |
1,900
| – | – | 0.05% | 171 |
|
|
2018
Q3 | $98K | Hold |
1,900
| – | – | 0.04% | 187 |
|
|
2018
Q2 | $79K | Hold |
1,900
| – | – | 0.04% | 206 |
|
|
2018
Q1 | $84K | Hold |
1,900
| – | – | 0.03% | 214 |
|
|
2017
Q4 | $96K | Hold |
1,900
| – | – | 0.04% | 208 |
|
|
2017
Q3 | $96K | Hold |
1,900
| – | – | 0.04% | 202 |
|
|
2017
Q2 | $97K | Hold |
1,900
| – | – | 0.04% | 191 |
|
|
2017
Q1 | $76K | Hold |
1,900
| – | – | 0.04% | 209 |
|
|
2016
Q4 | $91K | Hold |
1,900
| – | – | 0.04% | 195 |
|
|
2016
Q3 | $70K | Hold |
1,900
| – | – | 0.03% | 222 |
|
|
2016
Q2 | $44K | Hold |
1,900
| – | – | 0.02% | 266 |
|
|
2016
Q1 | $77K | Hold |
1,900
| – | – | 0.04% | 204 |
|
|
2015
Q4 | $118K | Buy |
1,900
+300
| +19% | +$16.2K | 0.06% | 172 |
|
|
2015
Q3 | $65K | Buy |
1,600
+900
| +129% | +$46.6K | 0.04% | 223 |
|
|
2015
Q2 | $40K | Buy |
700
+100
| +17% | +$6.36K | 0.02% | 284 |
|
|
2015
Q1 | $38K | Hold |
600
| – | – | 0.02% | 265 |
|
|
2014
Q4 | $37K | Hold |
600
| – | – | 0.02% | 273 |
|
|
2014
Q3 | $23K | Hold |
600
| – | – | 0.02% | 353 |
|
|
2014
Q2 | $21K | Buy |
600
+400
| +200% | +$12.6K | 0.02% | 357 |
|
|
2014
Q1 | $9K | Hold |
200
| – | – | 0.01% | 434 |
|
|
2013
Q4 | $8K | Hold |
200
| – | – | 0.01% | 459 |
|
|
2013
Q3 | $8K | Hold |
200
| – | – | 0.01% | 447 |
|
|
2013
Q2 | $5K | Buy |
+200
| New | +$4.25K | ﹤0.01% | 488 |
|
Other funds holding IONS
BG
TBC
PAMS
Kistler-Tiffany Companies's IONS Position: Q2 2023 in Review
Kistler-Tiffany Companies held its Ionis Pharmaceuticals (IONS) position steady in Q2 2023 at 1,281 shares worth $52.6K. The position accounts for 0.01% of the portfolio, ranked #483.
Kistler-Tiffany Companies first reported a position in IONS in Q2 2013 and has held it in 41 quarters since. The position peaked at $148K in Q1 2019. 304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.
- Kistler-Tiffany Companies held 1,281 shares of Ionis Pharmaceuticals worth $52.6K as of Q2 2023.
- Kistler-Tiffany Companies left its Ionis Pharmaceuticals share count unchanged in Q2 2023.
- Ionis Pharmaceuticals made up 0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #483 holding.
- Kistler-Tiffany Companies first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's Ionis Pharmaceuticals position peaked at $148K in Q1 2019.
- 304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.